Aopia launches NanoEX™ at 2024 ISEV conference

Aopia Biosciences officially launches the NanoEX™ Automated Bio-nanoparticle Isolation Platform on May 12th, 2024 at the 2024 ISEV annual conference, Melbourne, Australia.

The NanoEX™ is the next generation platform for isolating bio-nanoparticles, such as extracellular vesicles (EV), lipid nanoparticles (LNP), and gene therapy vectors. The system uses a patent-pending Asymmetric Nanopore Membrane (ANM) technology to revolutionize filtration-based bio-nanoparticle isolation and provides unparalleled yield, purity, and convenience over the existing technologies, such as tangential flow filtration (TTF).

With greater than 90% recovery rate and over 99.9% free-protein removal, NanoEX™ will help to significantly advance EV research, diagnostics, therapeutics, and cosmetics, and establish new gold standard for bio-nanoparticle purification.